Heart Disease Trial, Recruiting (NCT06579807)

Heart Disease Trial, Recruiting NCT06579807 Sponsor: Instituto Nacional de Cardiologia de Laranjeiras Condition: Heart Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06579807 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Heart Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are between 40 and 70 years old (any sex) and have been diagnosed with coronary artery disease (a condition affecting the heart's blood supply), such as a heart attack, unstable chest pain, or significant blockages found during a heart artery scan, and you are entering a cardiac rehabilitation program at HUPE
You are between 40 and 70 years old (any sex) and are in generally good health with no known heart artery disease (this applies to the healthy comparison group)

Who may not be able to join:

You have been diagnosed with heart failure, a lung disease, Chagas disease, or tuberculosis
You have been regularly exercising 3 or more days per week for at least 30 minutes per session over the past 6 months
You are considered underweight, meaning your body mass index (BMI) is below 18.5 (confirm with trial site if unsure of your BMI)
You are a current smoker
You are considered obese, meaning your body mass index (BMI) is 30 or above (confirm with trial site if unsure of your BMI)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 5 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Juliana Borges, PhD, Rio de Janeiro State University

Phone: +55212234

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06579807

Sponsor: Instituto Nacional de Cardiologia de Laranjeiras

Phase: Not Applicable

Status: Recruiting

Condition: Heart Disease

Trial contact: +55212234

More information: https://clinicaltrials.gov/study/NCT06579807

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are between 40 and 70 years old (any sex) and have been diagnosed with coronary artery disease (a condition affecting the heart's blood supply), such as a heart attack, unstable chest pain, or significant blockages found during a heart artery scan, and you are entering a cardiac rehabilitation program at HUPE
You are between 40 and 70 years old (any sex) and are in generally good health with no known heart artery disease (this applies to the healthy comparison group)

Who may not be able to join:

You have been diagnosed with heart failure, a lung disease, Chagas disease, or tuberculosis
You have been regularly exercising 3 or more days per week for at least 30 minutes per session over the past 6 months
You are considered underweight, meaning your body mass index (BMI) is below 18.5 (confirm with trial site if unsure of your BMI)
You are a current smoker
You are considered obese, meaning your body mass index (BMI) is 30 or above (confirm with trial site if unsure of your BMI)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 5 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Instituto Nacional de Cardiologia de Laranjeiras

Registry

ClinicalTrials.gov

Start date

1 October 2024

Est. completion

31 December 2026

Where this trial is recruiting

🇧🇷 Brazil

Primary endpoints

Carotid intima-media thickness

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov